TC-1827

TC-1827 is an orally active, selective agonist of the α 4 β 2 nicotinic receptors.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

TC-1827 is an orally active, selective agonist of the α 4 β 2 nicotinic receptors. Administration of TC-1827 improved memory and learning in a variety of rodents and increased long-term potentiation in hippocampal slices. In addition, the compound was without significant cardiovascular side effects, except for a small, transient rise in arterial blood pressure.

The pro-cognitive effects of TC-1827 last much longer than the short half-life (0.2–1.0 hours) would suggest.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1362878272 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.